Metabolic syndrome beware, PCSK9 inhibitors are here

Sollus NW Family Medicine Residency, Grandview, WA The corresponding author is Mario Gumina, DO; [email protected] The author declares no conflict of interest.

Authors

Publication Details

Journal
Evidence-Based Practice
Published
2024-08-22
DOI
https://doi.org/10.1097/ebp.0000000000002254
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic syndrome beware, PCSK9 inhibitors are here

Mario Gumina
Evidence-Based Practice
Lipoproteins and Cardiovascular Health
article

Metabolic syndrome beware, PCSK9 inhibitors are here

Mario Gumina
article en

Abstract

Sollus NW Family Medicine Residency, Grandview, WA The corresponding author is Mario Gumina, DO; [email protected] The author declares no conflict of interest.

Evidence-Based PracticeVol. 28(4)
Openalex Percentile: Top 75%
Lipoproteins and Cardiovascular Health
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Metabolic syndrome beware, PCSK9 inhibitors are here — Mario Gumina · Evidence-Based Practice (2024) | TGRS Research Map | TGRS